Matches in SemOpenAlex for { <https://semopenalex.org/work/W2808828292> ?p ?o ?g. }
- W2808828292 endingPage "448" @default.
- W2808828292 startingPage "441" @default.
- W2808828292 abstract "The recommended treatment for refractory status epilepticus (RSE) is the use of anesthetic agents, but evidence regarding the agent of choice is lacking. This study was designed to compare target-controlled infusion of propofol versus midazolam for the treatment of RSE regarding seizure control and complications.This prospective, randomized study recruited 23 adult patients with RSE due to any etiology and treated with either propofol or midazolam titrated to clinical seizure cessation and gradual tapering thereafter. The primary outcome measure was seizure control and the secondary outcomes were duration of the Intensive Care Unit stay and duration of mechanical ventilation, occurrence of super RSE (SRSE), and complications.We recruited 23 patients (male:female = 18:5) into this study (propofol Group-11; midazolam Group-12). Overall, seizure control was noted in 34.8%, with successful seizure control in 45% of patients in the propofol group and 25% in midazolam group (P = 0.4). Mortality was similar in both the groups (propofol group [8/11; 72.7%] compared to the midazolam group [7/12; 58.3%] [P = 0.667]). The duration of hospital stay was significantly shorter in the propofol group compared to midazolam (P = 0.02). The overall incidence of SRSE was 69.5% in this study. The complication rate was not significantly different between the groups.The choice of anesthetic agent does not seem to affect the overall outcome in RSE and SRSE. Target-controlled propofol infusion was found to be equal in its efficacy to midazolam for the treatment of RSE. High mortality might be due to SRSE secondary to the underlying brain pathology." @default.
- W2808828292 created "2018-06-29" @default.
- W2808828292 creator A5005638602 @default.
- W2808828292 creator A5017758507 @default.
- W2808828292 creator A5034502348 @default.
- W2808828292 creator A5035979756 @default.
- W2808828292 creator A5037138405 @default.
- W2808828292 creator A5041124977 @default.
- W2808828292 creator A5045863251 @default.
- W2808828292 creator A5065407425 @default.
- W2808828292 creator A5069822805 @default.
- W2808828292 date "2018-01-01" @default.
- W2808828292 modified "2023-10-01" @default.
- W2808828292 title "A comparative study of midazolam and target-controlled propofol infusion in the treatment of refractory status epilepticus" @default.
- W2808828292 cites W1976802305 @default.
- W2808828292 cites W1988358928 @default.
- W2808828292 cites W1988502678 @default.
- W2808828292 cites W1997921700 @default.
- W2808828292 cites W2002406854 @default.
- W2808828292 cites W2008233442 @default.
- W2808828292 cites W2026289809 @default.
- W2808828292 cites W2027311472 @default.
- W2808828292 cites W2029569324 @default.
- W2808828292 cites W2045765644 @default.
- W2808828292 cites W2058772453 @default.
- W2808828292 cites W2063899003 @default.
- W2808828292 cites W2071725069 @default.
- W2808828292 cites W2074130919 @default.
- W2808828292 cites W2074702640 @default.
- W2808828292 cites W2081154155 @default.
- W2808828292 cites W2081930823 @default.
- W2808828292 cites W2082934328 @default.
- W2808828292 cites W2090675376 @default.
- W2808828292 cites W2129658473 @default.
- W2808828292 cites W2132196633 @default.
- W2808828292 cites W2133025181 @default.
- W2808828292 cites W2134576429 @default.
- W2808828292 cites W2156680622 @default.
- W2808828292 cites W2158511203 @default.
- W2808828292 cites W4241786992 @default.
- W2808828292 cites W4250028527 @default.
- W2808828292 cites W4254591948 @default.
- W2808828292 cites W4367436795 @default.
- W2808828292 doi "https://doi.org/10.4103/ijccm.ijccm_327_17" @default.
- W2808828292 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6020637" @default.
- W2808828292 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29962746" @default.
- W2808828292 hasPublicationYear "2018" @default.
- W2808828292 type Work @default.
- W2808828292 sameAs 2808828292 @default.
- W2808828292 citedByCount "11" @default.
- W2808828292 countsByYear W28088282922019 @default.
- W2808828292 countsByYear W28088282922020 @default.
- W2808828292 countsByYear W28088282922021 @default.
- W2808828292 countsByYear W28088282922022 @default.
- W2808828292 crossrefType "journal-article" @default.
- W2808828292 hasAuthorship W2808828292A5005638602 @default.
- W2808828292 hasAuthorship W2808828292A5017758507 @default.
- W2808828292 hasAuthorship W2808828292A5034502348 @default.
- W2808828292 hasAuthorship W2808828292A5035979756 @default.
- W2808828292 hasAuthorship W2808828292A5037138405 @default.
- W2808828292 hasAuthorship W2808828292A5041124977 @default.
- W2808828292 hasAuthorship W2808828292A5045863251 @default.
- W2808828292 hasAuthorship W2808828292A5065407425 @default.
- W2808828292 hasAuthorship W2808828292A5069822805 @default.
- W2808828292 hasBestOaLocation W28088282921 @default.
- W2808828292 hasConcept C118552586 @default.
- W2808828292 hasConcept C120665830 @default.
- W2808828292 hasConcept C121332964 @default.
- W2808828292 hasConcept C126322002 @default.
- W2808828292 hasConcept C141071460 @default.
- W2808828292 hasConcept C142424586 @default.
- W2808828292 hasConcept C168563851 @default.
- W2808828292 hasConcept C2776277131 @default.
- W2808828292 hasConcept C2776376669 @default.
- W2808828292 hasConcept C2776814716 @default.
- W2808828292 hasConcept C2777080012 @default.
- W2808828292 hasConcept C2777341932 @default.
- W2808828292 hasConcept C2778000748 @default.
- W2808828292 hasConcept C2778162923 @default.
- W2808828292 hasConcept C2778186239 @default.
- W2808828292 hasConcept C42219234 @default.
- W2808828292 hasConcept C61511704 @default.
- W2808828292 hasConcept C71924100 @default.
- W2808828292 hasConcept C87355193 @default.
- W2808828292 hasConceptScore W2808828292C118552586 @default.
- W2808828292 hasConceptScore W2808828292C120665830 @default.
- W2808828292 hasConceptScore W2808828292C121332964 @default.
- W2808828292 hasConceptScore W2808828292C126322002 @default.
- W2808828292 hasConceptScore W2808828292C141071460 @default.
- W2808828292 hasConceptScore W2808828292C142424586 @default.
- W2808828292 hasConceptScore W2808828292C168563851 @default.
- W2808828292 hasConceptScore W2808828292C2776277131 @default.
- W2808828292 hasConceptScore W2808828292C2776376669 @default.
- W2808828292 hasConceptScore W2808828292C2776814716 @default.
- W2808828292 hasConceptScore W2808828292C2777080012 @default.
- W2808828292 hasConceptScore W2808828292C2777341932 @default.
- W2808828292 hasConceptScore W2808828292C2778000748 @default.
- W2808828292 hasConceptScore W2808828292C2778162923 @default.